#AACR26

Today at #AACR26 @zeyunlu.bsky.social, a research fellow in @sashagusevposts.bsky.social’s lab at @danafarber.bsky.social, presents findings that LLM-based extraction of unstructured clinical notes can provide scalable and accurate characterization of immune-related side effects. ➡️ bit.ly/4mxMtyF

Suart H. Orkin, MD, recipient of The Breakthrough Prize in Life Sciences

Suart H. Orkin, MD, has been honored with The Breakthrough Prize in Life Sciences for discovering how the body turns off fetal hemoglobin after birth, a finding that led to a new treatment strategy for sickle cell disease. Learn more: bit.ly/4cvCTHW

Dr. Omar Nadeem of Dana-Farber Cancer Institute presenting at #AACR26

At the #AACR26 press conference, Dr. Omar Nadeem of @danafarber.bsky.social presents results of the phase 2 CAR-PRISM clinical trial, the first to investigate CAR T-cell therapy in pts with high-risk smoldering multiple myeloma. The study also published today at @natmed.nature.com: bit.ly/3Qpatba

#AACR26

Dr. Alice Shaw @danafarber.bsky.social will highlight emerging science shaping the future of global cancer research and clinical care in today’s #AACR26 Opening Plenary. Learn more: brnw.ch/21wRXs0

#AACR26

Congratulations to @danafarber.bsky.social’s Dr. Alice Shaw, Dr. Kimberly Stegmaier and Dr. Matthew Vander Heiden who were elected as Fellows of the @theaacr.bsky.social Academy Class of 2026. Read more: bit.ly/4suWu0L

Dana-Farber Cancer Institute

This weekend, our researchers will present more than 50 studies at the American Association for Cancer Research (AACR) Annual Meeting in San Diego. Learn more about our #AACR26 highlights here: bit.ly/41GQR4I

How Dana-Farber’s CEO is reshaping cancer care - The Boston Globe Dr. Benjamin Ebert, who previously served as chair of the department of medical oncology at the institute for seven years, shared with the Boston Globe his ideas and vision for Dana-Farber’s future.

There is no shortage of innovation when it comes to the vision of our future cancer hospital. Benjamin L. Ebert, MD, PhD, sat down with the @bostonglobe.com Media to discuss the work behind bringing these ideas into fruition.

Changing the Trajectory of Brain Cancer with a Stronger Immune Defense A virus-based therapy may help the immune system target glioblastoma by turning “cold” tumors into active ones.

While many physician-scientists have attempted to treat glioblastoma, it remains one of the most difficult human cancer types to manage. Learn more about how researchers are changing the trajectory of brain cancer with a stronger immune defense: bit.ly/3PS3fwa

Goldie Taylor

@goldietaylor.bsky.social was recently named to Becker's Healthcare's 2026 CMOs to Know list. Please join us in congratulating her on this recognition.

View the list here: bit.ly/4c40VcV

New research from Dana-Farber Cancer Institute's Spiegelman Lab

New research in @natureportfolio.nature.com by @danafarber.bsky.social's Spiegelman Lab reveals that irisin-driven cell-cell and inter-tissue interactions improve obesity & glucose intolerance and increase energy expenditure, with no reduced food intake and muscle loss in obese mice. bit.ly/4sdGhgf

Ursula A. Matulonis, MD

Ursula A. Matulonis, MD, brings expert insights into the most recent breakthroughs, evolving standards, and emerging therapies across gynecologic cancers in her series with @onclive.bsky.social, From Discovery to Delivery: Charting Progress in Gynecologic Oncology. Watch here: bit.ly/40xFiMu

Magnolia Contreras, vice president of community health

Magnolia Contreras, vice president of community health, is the recipient of @mapublichealth.org’s Lemuel Shattuck Award for significant contributions to public health practice. Please join us in congratulating her on this recognition.

Learn more: bit.ly/4dYYwma

Stephen Dragotakes, NPh, BCNP, FAPhA

Congratulations to Stephen Dragotakes, NPh, BCNP, FAPhA, operations manager of our Molecular Cancer Imaging Facility, for receiving the 2026 William H. Briner Distinguished Achievement Award in Nuclear Pharmacy Practice from the American Pharmacists Association.

Learn more: bit.ly/4t95jOL

Postgraduate Physician Assistant Oncology Fellowship

Applications are open for the 5th PA Oncology Fellowship are open! Submissions are due by May 1. Learn more and apply here: bit.ly/4sVVFie

A light blue graphic that reads "Thank you, doctors!" in navy text.

Today and every day, we thank the incredible doctors at @danafarber.bsky.social and beyond for making a difference in the lives of patients and their families. Their expert, compassionate, and equitable care brings us closer to a world free from the burden of cancer. 💙

#NationalDoctorsDay

Dana-Farber Team Develops Open-Access Predictive Tool to Improve Monitoring of Smoldering Multiple Myeloma | Dana-Farber Cancer Institute Dana-Farber Cancer Institute investigators have developed an online, easy-to-use tool that more accurately predicts when a precursor blood condition called smoldering multiple myeloma is likely to turn into active cancer than existing predictive models. It identifies patients who are at a high risk of developing multiple myeloma and would benefit from treatment and enables doctors to spare those at low risk of progression from unnecessary treatment.

Our investigators have developed a free, online, easy-to-use tool that more accurately predicts when a precursor blood condition called smoldering multiple myeloma is likely to turn into active cancer than existing predictive models. Learn more: bit.ly/4dLwxX2

Dana Farber Cancer Institute opens new on-site food pantry with Stop & Shop donation - Boston News, Weather, Sports | WHDH 7News BOSTON (WHDH) - Dana Farber Cancer Institute celebrated the opening of a new food-pantry with the help of Stop & Shop on Wednesday. Stop &<a class="excerpt-read-more" href="https://whdh.com/news/dana-farber-cancer-institute-opens-new-on-site-food-pantry-with-stop-shop-donation/">Read More</a>

Featured on 7News Boston: Dana-Farber President and CEO Benjamin L. Ebert says the new food pantry at @danafarber.bsky.social supported by Stop & Shop will help combat #foodinsecurity which he called a “major determinant of outcome” in patients facing cancer and their households. ➡️ bit.ly/4t9UtIa

In Celebration of a Decades-Long Journey of Discovery and Innovation On October 1, 2025, Benjamin L. Ebert, MD, PhD, celebrated the 1-year anniversary of being named President and Chief Executive Officer (CEO) of Dana-Farber Cancer Institute in Boston. He also holds th...

Exposure to clinical medicine and research from an early age led to @danafarber.bsky.social President and CEO Dr. Benjamin L. Ebert to a career focused on the genetic foundation and treatment of hematologic malignancies. Read more in @ascopost.bsky.social: bit.ly/4sRrqJT

Dr. Kathleen Burns of Dana-Farber Cancer Institute

Congrats to @danafarber.bsky.social’s Dr. Kathleen Burns on being named an @aaas.org Fellow for pioneering contributions to understanding the role of mobile genetic elements in cancer.

➡️ bit.ly/47pobAy

Today @danafarber.bsky.social launched its new food pantry with a $1 million gift from Stop & Shop to help combat #foodinsecurity and advance health equity during cancer treatment. It currently serves pediatric households with plans to expand access. Read more: bit.ly/4symGZa

Physician Assistant Virtual Info Session

Join us for a virtual physician assistant careers info session on April 7 at 6 p.m. Meet with recruiters and leaders to learn more about the variety of opportunities available.

Register here: bit.ly/20260406-pa-...

Christina Lau

Christina Lau, Assistant General Counsel II, has been selected as an Up & Coming Lawyer in Massachusetts Lawyers Weekly’s Excellence in the Law 2026 list. View the full list of honorees here: bit.ly/4sdK9P4

Craig Bunnell, MD, MPH, MBA

Congratulations to Craig Bunnell, MD, MPH, MBA, on being named to Becker’s Healthcare's CMOs to Know list. View the list here: bit.ly/4bB7yUT

Life expectancy gap between Black residents and other Bostonians has doubled over the past decade - The Boston Globe The life expectancy gap between Black residents and the rest of Boston has doubled, largely due to preventable deaths, according to a new report.

“Hope should not be restricted to just affluent communities. Hope should be accessible to all.” @danafarber.bsky.social’s Chief Clinical Access Officer, Dr. Chris Lathan, discusses the life expectancy gap between Black residents and other Bostonians in this @BostonGlobe article: bit.ly/4b9vyys

Irene Ghobrial, MD

Congratulations to Irene Ghobrial, MD, recipient of Senior Researcher Prize of the Francesca Cassinelli Award for 2025. The award recognizes Ghobrial's exceptional scientific excellence, international leadership, and impactful contributions to multiple myeloma.

Learn more: bit.ly/4cFHFV4

Nicholas Polizzi, PhD, of Dana-Farber Cancer Institute

In a new study published in @natmethods.nature.com, @danafarber.bsky.social’s @nickpolizzi.bsky.social uses features from a pretrained neural network to train a logistic regression model, AF2BIND, which could be used for drug discovery and uncovering functional sites in proteins.

➡️ rdcu.be/e7SnX

Forbes 250: America's Greatest Innovators The Forbes Innovator 250: America's Greatest Innovators showcases the visionaries shaping our future. Find the full list of great minds and the mark they are leaving on our history.

Congratulations to Nobel Laureate William G. Kaelin Jr., MD, on being named to @forbes.com’s America’s Greatest Innovators list. View the full list here: bit.ly/3PeSxiR

Lily Kabarame, BSN, RN, of Dana-Farber Cancer Institute

Congratulations to Lily Kabarame, BSN, RN, recipient of the 2026 New England Regional Black Nurses Association Excellence in Nursing Practice Award. Lily is recognized for her work as an oncology nurse navigator with the @danafarber.bsky.social Lank Center for Genitourinary Oncology.

Stuart Orkin, MD

For five decades, Stuart Orkin, MD, has used emerging genetic tools to rewrite what medicine can do for blood disorders — and help turn sickle cell and beta thalassemia into curable diseases. But, says Orkin, “the problem is never fully solved.” ⬇️ bit.ly/47oF2mO

How Colorectal Cancer Is Missed in Women “There's a fable out there that colorectal cancer is an old man’s disease. We have to fight that." 

Why is #colorectalcancer rising in younger adults? Featured in @katiecouric.bsky.social Media, @danafarber.bsky.social’s Dr. Kimmie Ng discusses the top theories researchers are investigating and risk factors you don't want to ignore. #ColorectalCancerAwarenessMonth

➡️ bit.ly/4ujThU7